Clinical Study

Clinical Significance of Optic Disc Progression by Topographic Change Analysis Maps in Glaucoma: An 8-Year Follow-Up Study

Table 3

Univariable Cox models for the hazard of glaucoma progression by TCA status and other potential prognostic factors.

Covariate  Stereophotograph and/or Visual FieldStereophotographsVisual Fields
HR95% CI HR95% CI HR95% CI

TCA progression
 Stable1.001.001.00
 Progressed1.18(0.39, 3.63)0.760.99(0.29, 3.36)0.993.70(0.37, 37.14)0.27
Sex
 Male1.001.001.00
 Female1.52(0.54, 4.33)0.431.53(0.48, 4.84)0.473.56(0.39, 32.63)0.26
MRA at baseline
 Within normal limits1.001.001.00
 Borderline1.56(0.36, 6.72)0.552.35(0.47, 11.73)0.30 1.02(0.10, 10.81)0.99
 Outside normal limits1.05(0.34, 3.24)0.941.31(0.33, 5.32)0.700.45(0.07, 2.76)0.39
 CCT (per 50 μm thicker)0.85(0.46, 1.58)0.610.90(0.47, 1.74)0.760.48(0.16, 1.44)0.19
 MD at baseline (per 1 dB larger)1.03(0.88, 1.21)0.691.08(0.89, 1.32)0.430.93(0.75, 1.16)0.53
 PSD at baseline (per 1 dB larger)1.03(0.91, 1.17)0.630.99(0.85, 1.16)0.921.13(0.94, 1.37)0.19
 VFI at baseline (per 10 units)0.99(0.57, 1.73)0.971.11(0.56, 2.19)0.770.77(0.33, 1.78)0.54
 Age at baseline (per decade)1.11(0.62, 1.97)0.731.13(0.59, 2.16)0.701.91(0.54, 6.76)0.31
 Age at enrollment (per decade)1.12(0.64, 1.99)0.681.15(0.61, 2.17)0.661.78(0.53, 6.01)0.35
 Preenrollment followup (per year)1.09(0.78, 1.52)0.611.08(0.75, 1.55)0.680.88(0.42, 1.83)0.73
 Vertical c/d ratio at enrollment (per unit)2.98(0.16, 57.01)0.473.98(0.11, 138.27)0.442.95(0.03, 311.79)0.65
 Mean HRT topography SD at baseline (per 1 µm)1.04(0.98, 1.11)0.171.04(0.97, 1.11)0.271.05(0.95, 1.15)0.35

MRA: moorfields regression analysis; OHT: ocular hypertension; CCT: central corneal thickness; MD: mean deviation; PSD: pattern standard deviation; VFI: visual field index; c/d: cup/disc; HR: hazard ratio; SD: standard deviation; CI: confidence interval; dots (.) denote nonestimable quantities.